General Dynamics Corporation — 7.55/10

BUY
NYSE: GD  |  High-quality defense prime with structural oligopoly / sole-source moats in three of four segments (~74% of revenue). Record $118.0B backlog (+30% YoY). 12+ year credible beat-and-raise management. Positive and growing full-year FCF. Zero China exposure at a fair, slightly-below-peer ~20.6x forward P/E. An own-the-leader, fair-price compounder — held below 8 by a steady (not inflecting) financial trajectory and no contrarian sentiment edge. Quality gate: PASS (0 NOs).
Financial Trends
7/10
Rev +10.1%, FCF +23.9% | Steady compounder
Oligopoly
PASS
Sole-source in 3 of 4 segments | ~74% of rev
Sentiment
4/10
Consensus Buy, no divergence | No edge
Concerns / Risks
8/10
No China, fair multiple, clear catalysts
Company overview

General Dynamics is a four-segment aerospace and defense prime. Its two largest defense franchises — Marine Systems (31.8% of revenue) and Combat Systems (17.6%) — sit in genuine oligopoly / sole-source structures, anchored by a record $118.0B backlog (+30% YoY). Aerospace/Gulfstream (24.9%) is a durable top-3 large-cabin business-jet maker; Technologies/GDIT (25.6%) is the one drag, a fragmented, recompete-driven federal-IT business with no dominant share.

The thesis is "leaders remain leaders": GD is a high-quality compounder trading at a fair price. It clears the quality gate cleanly (oligopoly YES, growing FCF YES, 12+ year management track record YES). What holds the composite to a solid-but-not-top 7.55 is (1) a steady rather than inflecting financial trajectory — revenue YoY gently decelerating off elevated 2024 comps and segment margins flat at ~10%; and (2) a genuinely weak inverted-sentiment dimension — there is no contrarian edge, as management's FY26 EPS guide sits below the ~$16.70 consensus, the street is already a crowded Buy, and insiders are net sellers.

CEO Phebe Novakovic (since 2013) Revenue Growth +10.1% FY2025 ($52.6B)
Secular Tailwinds Submarines / European rearm / Biz-jet FCF Trajectory Growing (+23.9% to $3.96B)
Record Backlog $118.0B (+30% YoY) FYE December 31
Quality Gate PASS (0 NOs) China Exposure Effectively zero

Score breakdown
7
/ 10
Financial Trends Weight: 25% | Contribution: 1.75
FY2025 revenue +10.1% to $52.6B, operating earnings +11.7%, full-year FCF +23.9% to $3.96B, declining share count (272.4M), steady de-leveraging (total debt $11.5B to $8.0B since FY21). No red flags. Held to 7 because revenue YoY is gently decelerating off 2024 comps and segment margins are flat at ~10% rather than inflecting.
8
/ 10
Thematic Exposure Weight: 35% | Contribution: 2.80
Passes the oligopoly gate decisively. Marine (one of only two US nuclear-sub yards, ~78% of Columbia-class), Combat (sole-source on M1 Abrams and Stryker), and Aerospace/Gulfstream (top-3 large-cabin biz jets) are structural oligopolies / monopolies — ~74% of revenue. Record $118.0B backlog. Capped short of a perfect score only by fragmented Technologies/GDIT (25.6% of revenue, +2.6%).
8
/ 10
Management Quality Weight: 20% | Contribution: 1.60
Phebe Novakovic CEO since 2013 (12+ years) with a stable CFO. ~92% hit rate against FY2025 guidance set four quarters earlier — beat on revenue, EPS ($15.45 vs ~$14.80), Gulfstream deliveries (158 vs 150), and FCF conversion (94% vs an 80-85% bar raised to low-90s mid-year). Zero red flags. Capped at 8 by the 2024 G700 delivery stumble and not-yet-mature segment margins.
4
/ 10
Investor Sentiment (Inverted) Weight: 5% | Contribution: 0.20
No management-street divergence to exploit. Q&A reads as analysts handing management the bull case and management gently moderating it. Management's FY2026 EPS guide ($16.1-$16.2) sits below the ~$16.70 consensus; the street is a crowded Buy (18/15/1) with a ~15% upside target; insiders are net sellers. A well-owned consensus long with no contrarian edge.
8
/ 10
Concerns, Catalysts & Risks Weight: 15% | Contribution: 1.20
Best-in-class risk profile paired with multiple credible catalysts. Zero China exposure. Forward P/E ~20.6x sits slightly below the prime peer average (premium to LMT, discount to Northrop). Catalysts: G800 ramp / G700 margin maturation, +30% backlog conversion, submarine throughput, supportive defense budget. Only mild regulatory friction (tariffs, CR timing, DOGE on GDIT).
Dimension Score Weight Weighted
Financial Trends 7 25% 1.75
Thematic Exposure 8 35% 2.80
Management Quality 8 20% 1.60
Investor Sentiment (Inverted) 4 5% 0.20
Concerns, Catalysts & Risks 8 15% 1.20
Composite 100% 7.55

Summary thesis

A high-quality defense prime that scores 7.55/10 — a genuine quality compounder trading at a fair price. GD holds structural oligopoly / sole-source moats in three of four segments (~74% of revenue): Marine Systems (one of only two US nuclear-sub yards), Combat Systems (sole-source on M1 Abrams and Stryker), and Aerospace/Gulfstream (top-3 large-cabin business jets). A record $118.0B backlog (+30% YoY), 12+ years of credible beat-and-raise management, positive and growing full-year FCF (+23.9% to $3.96B), and effectively zero China exposure round out a clean quality profile.

Quality gate: PASS (0 NOs). Oligopoly YES. Positive and growing FCF YES. Management 3+ year track record YES. No cap applied — the company is scored normally.

What holds the composite below 8 is twofold: (1) financial trajectory is steady rather than inflecting — revenue YoY gently decelerating off 2024 comps and segment margins flat at ~10%; and (2) the inverted-sentiment dimension is genuinely weak (4/10) — no contrarian edge, as management's FY26 EPS guide sits below the ~$16.70 consensus, the street is a crowded Buy, and insiders are net sellers.


Positioning

This is an own-the-leader, fair-price compounder — not a mispriced-divergence idea. The three highest-conviction dimensions (Thematic 8, Management 8, Concerns/Risks 8) all reflect durable, structural quality: an irreplaceable nuclear / heavy-manufacturing industrial base, sole-source platform incumbency, a record funded backlog, and a best-in-class risk profile (no China, fair multiple, clear catalysts).

The two constraints on the score are both about edge and trajectory, not business quality. Financials are healthy but steady (7/10) — GD compounds durably rather than inflecting. And sentiment (4/10) is the binding drag: the defense-leader thesis is fully understood and owned by the street, so there is no differentiated insight to exploit. Management guides conservatively (FY26 EPS below consensus), the sell-side is a consensus Buy with ~15% upside already in targets, and insiders are net sellers through 2026.

At ~20.6x forward P/E — slightly below the prime peer average — you pay a fair multiple for a leader with accelerating backlog conversion and improving FCF. The score rewards the quality and the price, and correctly penalizes the absence of a contrarian angle.


Data sourced from Daloopa (company_id: 403). Price/market cap per FMP as of 2026-06-24. Analysis date: 2026-06-24.